|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PRKAG2-WASL (FusionGDB2 ID:68649) |
Fusion Gene Summary for PRKAG2-WASL |
Fusion gene summary |
Fusion gene information | Fusion gene name: PRKAG2-WASL | Fusion gene ID: 68649 | Hgene | Tgene | Gene symbol | PRKAG2 | WASL | Gene ID | 51422 | 8976 |
Gene name | protein kinase AMP-activated non-catalytic subunit gamma 2 | WASP like actin nucleation promoting factor | |
Synonyms | AAKG|AAKG2|CMH6|H91620p|WPWS | N-WASP|NWASP|WASPB | |
Cytomap | 7q36.1 | 7q31.32 | |
Type of gene | protein-coding | protein-coding | |
Description | 5'-AMP-activated protein kinase subunit gamma-2AMPK subunit gamma-2epididymis secretory sperm binding proteinprotein kinase, AMP-activated, gamma 2 non-catalytic subunit | neural Wiskott-Aldrich syndrome proteinWiskott-Aldrich syndrome like | |
Modification date | 20200320 | 20200327 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000392801, ENST00000287878, ENST00000418337, ENST00000433631, ENST00000492843, ENST00000461529, | ENST00000223023, | |
Fusion gene scores | * DoF score | 16 X 11 X 10=1760 | 6 X 5 X 6=180 |
# samples | 21 | 6 | |
** MAII score | log2(21/1760*10)=-3.06711419585854 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/180*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PRKAG2 [Title/Abstract] AND WASL [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PRKAG2(151292431)-WASL(123349277), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | PRKAG2-WASL seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. PRKAG2-WASL seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. PRKAG2-WASL seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. PRKAG2-WASL seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PRKAG2 | GO:0006469 | negative regulation of protein kinase activity | 17255938 |
Tgene | WASL | GO:0030041 | actin filament polymerization | 16767080 |
Tgene | WASL | GO:0045944 | positive regulation of transcription by RNA polymerase II | 16767080 |
Tgene | WASL | GO:1903526 | negative regulation of membrane tubulation | 18388313 |
Fusion gene breakpoints across PRKAG2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across WASL (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | MESO | TCGA-UT-A88C-01B | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - |
ChimerDB4 | MESO | TCGA-UT-A88C | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - |
Top |
Fusion Gene ORF analysis for PRKAG2-WASL |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000392801 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - |
In-frame | ENST00000287878 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - |
In-frame | ENST00000418337 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - |
In-frame | ENST00000433631 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - |
In-frame | ENST00000492843 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - |
intron-3CDS | ENST00000461529 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000287878 | PRKAG2 | chr7 | 151292431 | - | ENST00000223023 | WASL | chr7 | 123349277 | - | 5354 | 1369 | 493 | 2769 | 758 |
ENST00000418337 | PRKAG2 | chr7 | 151292431 | - | ENST00000223023 | WASL | chr7 | 123349277 | - | 4380 | 395 | 77 | 1795 | 572 |
ENST00000433631 | PRKAG2 | chr7 | 151292431 | - | ENST00000223023 | WASL | chr7 | 123349277 | - | 4744 | 759 | 240 | 2159 | 639 |
ENST00000492843 | PRKAG2 | chr7 | 151292431 | - | ENST00000223023 | WASL | chr7 | 123349277 | - | 4798 | 813 | 291 | 2213 | 640 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000287878 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - | 0.000218199 | 0.9997818 |
ENST00000418337 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - | 0.00019714 | 0.9998029 |
ENST00000433631 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - | 0.00103588 | 0.9989641 |
ENST00000492843 | ENST00000223023 | PRKAG2 | chr7 | 151292431 | - | WASL | chr7 | 123349277 | - | 0.000898486 | 0.9991015 |
Top |
Fusion Genomic Features for PRKAG2-WASL |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PRKAG2-WASL |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr7:151292431/chr7:123349277) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | WASL | chr7:151292431 | chr7:123349277 | ENST00000223023 | 0 | 11 | 277_392 | 39 | 506.0 | Compositional bias | Note=Pro-rich | |
Tgene | WASL | chr7:151292431 | chr7:123349277 | ENST00000223023 | 0 | 11 | 485_505 | 39 | 506.0 | Compositional bias | Note=Asp-rich | |
Tgene | WASL | chr7:151292431 | chr7:123349277 | ENST00000223023 | 0 | 11 | 203_216 | 39 | 506.0 | Domain | CRIB | |
Tgene | WASL | chr7:151292431 | chr7:123349277 | ENST00000223023 | 0 | 11 | 405_422 | 39 | 506.0 | Domain | WH2 1 | |
Tgene | WASL | chr7:151292431 | chr7:123349277 | ENST00000223023 | 0 | 11 | 433_450 | 39 | 506.0 | Domain | WH2 2 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 275_335 | 288 | 570.0 | Domain | CBS 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 357_415 | 288 | 570.0 | Domain | CBS 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 430_492 | 288 | 570.0 | Domain | CBS 3 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 504_562 | 288 | 570.0 | Domain | CBS 4 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 275_335 | 244 | 526.0 | Domain | CBS 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 357_415 | 244 | 526.0 | Domain | CBS 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 430_492 | 244 | 526.0 | Domain | CBS 3 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 504_562 | 244 | 526.0 | Domain | CBS 4 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 275_335 | 47 | 329.0 | Domain | CBS 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 357_415 | 47 | 329.0 | Domain | CBS 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 430_492 | 47 | 329.0 | Domain | CBS 3 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 504_562 | 47 | 329.0 | Domain | CBS 4 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 370_391 | 288 | 570.0 | Motif | Note=AMPK pseudosubstrate |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 370_391 | 244 | 526.0 | Motif | Note=AMPK pseudosubstrate |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 370_391 | 47 | 329.0 | Motif | Note=AMPK pseudosubstrate |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 319_322 | 288 | 570.0 | Nucleotide binding | AMP%2C ADP or ATP 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 383_384 | 288 | 570.0 | Nucleotide binding | AMP%2C ADP or ATP 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 458_459 | 288 | 570.0 | Nucleotide binding | AMP 3 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 474_477 | 288 | 570.0 | Nucleotide binding | AMP%2C ADP or ATP 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 530_531 | 288 | 570.0 | Nucleotide binding | AMP%2C ADP or ATP 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000287878 | - | 6 | 16 | 546_549 | 288 | 570.0 | Nucleotide binding | AMP 3 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 319_322 | 244 | 526.0 | Nucleotide binding | AMP%2C ADP or ATP 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 383_384 | 244 | 526.0 | Nucleotide binding | AMP%2C ADP or ATP 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 458_459 | 244 | 526.0 | Nucleotide binding | AMP 3 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 474_477 | 244 | 526.0 | Nucleotide binding | AMP%2C ADP or ATP 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 530_531 | 244 | 526.0 | Nucleotide binding | AMP%2C ADP or ATP 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000392801 | - | 6 | 16 | 546_549 | 244 | 526.0 | Nucleotide binding | AMP 3 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 319_322 | 47 | 329.0 | Nucleotide binding | AMP%2C ADP or ATP 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 383_384 | 47 | 329.0 | Nucleotide binding | AMP%2C ADP or ATP 1 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 458_459 | 47 | 329.0 | Nucleotide binding | AMP 3 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 474_477 | 47 | 329.0 | Nucleotide binding | AMP%2C ADP or ATP 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 530_531 | 47 | 329.0 | Nucleotide binding | AMP%2C ADP or ATP 2 |
Hgene | PRKAG2 | chr7:151292431 | chr7:123349277 | ENST00000418337 | - | 2 | 12 | 546_549 | 47 | 329.0 | Nucleotide binding | AMP 3 |
Tgene | WASL | chr7:151292431 | chr7:123349277 | ENST00000223023 | 0 | 11 | 34_141 | 39 | 506.0 | Domain | WH1 |
Top |
Fusion Gene Sequence for PRKAG2-WASL |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>68649_68649_1_PRKAG2-WASL_PRKAG2_chr7_151292431_ENST00000287878_WASL_chr7_123349277_ENST00000223023_length(transcript)=5354nt_BP=1369nt GAGCTGGTTTATTCTGCGGCCGAGGATTACATTTATGCACGAACGGGCTTACTGGTTCCAGATTCCCCACTTGGGCACAGGCATAGGAGG CTTGTTTTCCAAATTGCTGGTTTTAATTGCACCTGCCTTTCAGATTACCTCTGGGAATCTGTGGGAGGAGCCGAGAGGGTGGAAAATGTT TCTTAGCTTTGCAAAAGGAAGAAAACTTTGTCACCCAGCGGGAGACCTCAGCCACGAGTAACCCGGGGAGACACCAGAACCGGGACGGGC TTTGACTGATTTGCCTACGAGGGTTCCGTAGGAAAGGACGCTTGAATTCGGCGCTTCGGCGGCGGCGGCGGCCGCGCGAGTTCCCTGCTC ACCCTCCCTCTCCGCGGAAGTCCCCACGAGGTGGCTTCAGGGTGTAACAGAGCGCGCGGCTCCAGTCCGAAGGCAGCGGCCGGGGGAGGG AAGGAGGGGACCGAACCCCCGAGGAGTTTCGCAGAATCAACTTCTGGTTAGAGTTATGGGAAGCGCGGTTATGGACACCAAGAAGAAAAA AGATGTTTCCAGCCCCGGCGGGAGCGGCGGCAAGAAAAATGCCAGCCAGAAGAGGCGTTCGCTGCGCGTGCACATTCCGGACCTGAGCTC CTTCGCCATGCCGCTCCTGGACGGAGACCTGGAGGGTTCCGGAAAGCATTCCTCTCGAAAGGTGGACAGCCCCTTCGGCCCGGGCAGCCC CTCCAAAGGGTTCTTCTCCAGAGGCCCCCAGCCCCGGCCCTCCAGCCCCATGTCTGCACCTGTGAGGCCCAAGACCAGCCCCGGCTCTCC CAAAACCGTGTTCCCGTTCTCCTACCAGGAGTCCCCGCCACGCTCCCCTCGACGCATGAGCTTCAGTGGGATCTTCCGCTCCTCCTCCAA AGAGTCTTCCCCCAACTCCAACCCTGCTACCTCGCCCGGGGGCATCAGGTTTTTCTCCCGCTCCAGAAAAACCTCCGGCCTCTCCTCCTC TCCGTCAACACCCACCCAAGTGACCAAGCAGCACACGTTTCCCCTGGAATCCTATAAGCACGAGCCTGAACGGTTAGAGAATCGCATCTA TGCCTCGTCTTCCCCCCCGGACACAGGGCAGAGGTTCTGCCCGTCTTCCTTCCAGAGCCCGACCAGGCCTCCACTGGCATCACCGACACA CTATGCTCCCTCCAAAGCCGCGGCGCTGGCGGCGGCCCTGGGACCCGCGGAAGCCGGCATGCTGGAGAAGCTGGAGTTCGAGGACGAAGC AGTAGAAGACTCAGAAAGTGGTGTTTACATGCGATTCATGAGGTCACACAAGTGTTATGACATCGTTCCAACCAGTTCAAAGCTTGTTGT CTTTGATACTACATTACAAACTATGTCTTCAGCAGTGGTGCAGTTATATGCAGCAGATCGGAACTGTATGTGGTCAAAGAAGTGCAGTGG TGTTGCTTGTCTTGTTAAGGACAATCCACAGAGATCTTATTTTTTAAGAATATTTGACATTAAGGATGGGAAACTATTGTGGGAACAAGA GCTATACAATAACTTTGTATATAATAGTCCTAGAGGATATTTTCATACCTTTGCTGGAGATACTTGTCAAGTTGCTCTTAATTTTGCCAA TGAAGAAGAAGCAAAAAAATTTCGAAAAGCAGTTACAGACCTTTTGGGCCGTCGACAAAGGAAATCTGAGAAAAGACGAGATCCCCCAAA TGGTCCTAATCTACCCATGGCTACAGTTGATATAAAAAATCCAGAAATCACAACAAATAGATTTTATGGTCCACAAGTCAACAACATCTC CCATACCAAAGAAAAGAAGAAGGGAAAAGCTAAAAAGAAGAGATTAACCAAGGCAGATATAGGAACACCAAGCAATTTCCAGCACATTGG ACATGTTGGTTGGGATCCAAATACAGGCTTTGATCTGAATAATTTGGATCCAGAATTGAAGAATCTTTTCGATATGTGTGGAATCTCAGA GGCACAACTTAAAGACAGAGAAACATCAAAAGTTATATATGACTTTATTGAAAAAACAGGAGGTGTTGAAGCTGTTAAAAATGAACTGCG GAGGCAAGCACCACCACCTCCACCACCATCAAGGGGAGGGCCACCTCCTCCTCCTCCCCCTCCACACAACTCAGGTCCTCCTCCTCCTCC TGCTAGGGGAAGAGGCGCTCCTCCCCCACCACCTTCAAGAGCTCCCACAGCTGCACCTCCACCACCGCCTCCTTCCAGGCCAAGTGTAGC AGTCCCTCCACCACCGCCAAATAGGATGTACCCTCCTCCACCTCCAGCCCTTCCCTCCTCAGCACCTTCAGGGCCTCCACCACCACCTCC ATCTGTGTTGGGGGTAGGGCCAGTGGCACCACCCCCACCGCCTCCACCTCCACCTCCTCCTGGGCCACCGCCCCCGCCTGGCCTGCCTTC TGATGGGGACCATCAGGTTCCAACTACTGCAGGAAACAAAGCAGCTCTTTTAGATCAAATTAGAGAGGGTGCTCAGCTAAAAAAAGTGGA GCAGAACAGTCGGCCAGTGTCCTGCTCTGGACGAGATGCACTGTTAGACCAGATACGACAGGGTATCCAACTAAAATCTGTGGCTGATGG CCAAGAGTCTACACCACCAACACCTGCACCCACTTCAGGAATTGTGGGTGCATTAATGGAAGTGATGCAGAAAAGGAGCAAAGCCATTCA TTCTTCAGATGAAGATGAAGATGAAGATGATGAAGAAGATTTTGAGGATGATGATGAGTGGGAAGACTGATCTATATATTATATATATAT ATATATTTTTAAGGTGAAATACTAAACACTACTTTCTGTCTGTGGATTCTGTAAAATTATCATGTAAATGTTCTACCAATTTGCTGTATA TTTTTGTTGCCTTTTTTGCTTTTTTTTAATCTGTGCAATACCTCATTTAATCTGTAAAGGTTTGTCGTAATCCTCTACAAAGCTACTCCC TGTTATTGTGTGCAAGTTTACACCAGGATGCTCACTTGATTTGTGAATATTTTTCATTCCATCAACAAGGGAGTTTAAATACTATATGTG AGACTGACAAAAACCTTAATGTAATTTACTTATAATGCCAGAAGGAAAACACTATTTTCATACCCTACTTTTTCTGTACCTAAATTTTCT TAAAAAAAAATCTAGTATAGCACTACATTCTTTTTTAAGTGATGCAGACCTTAGTTTCTTTAGCCCCTTTATTTTGAATACAATGCTACA TATGAATGTTGAAGCTGATACATTGCACAGTTCTGTAGACATCACTACACCGATGTAGTTTCTCAAATTTTAGCAATATGCTCTACATAA AATCACTACAGAGATACTAGTGGGGAAGACGATTAACACACCTCTTACAGTAATACTGCCTGTTATTGGTATAGCAGTGGTATTTGCAGA CTGGGATCATAAGGAGCCCTTAAATACTTGTTATTGACTGGGGTTATTTTTATGCTGTAGCAAATGTGACAGGCTCTTTTTAGCAAAATT TTTGAAAATTTTTTTGGTATTACTCTGAAACAAAATTTAAGTTGGAGTTTCAGGGATTTAGGGAGTAGTTTTCATTCTACATGAACTGAG GTAATATTATGGTAACTCCAATATTTGGTTAAAAAAACTATACAAATCAGAATAGTACTAAAATACTGTAGAATTTTAGCATTTTTATTT TGCACTTTGTGTGGATTGAGGTGTTCAGAAATACCAACCATAAAAATGTAATCTAGTTGGCAAAGGTGTGCGCTAAAACACGGAACCGAA CATGCATTGATTTGGATAACTTTTGAGGGTTTTTGTCAAATAGCATGTGAAGAGTTACATTTTTCTTAAAAGATTGGTGGTCCCAATGTC AGAGTTCTTGGAACAGATAACTGAATGATAGATTTTTTTTTTTTAAAGATAAAACTTTACAACCTGCACATTTGTTATGCATACTAAATG GTGTGTTAAAATTAGGGTTTCTTTGCCTCTCTACACTACACTAATCTGCCTAAAGGTGGTTGTTTCATATTTATAATGCTAATTATCATA CCTACCTACTTTAAATTTTAGGTAGAAAATTATCTGATTTAAATACAAACATATTTTTCTCACATTGAGTAATATGCATAATGTAGTTCC AAATGTATTTCATTACTATAGTCACAATATCCAACTAAAAATTACGCTATCTAGAATTGTACCAACCAAAATCTCGTATTGGCAGATCTT GACAGGCTGGACCTGCAAGATGTGGCTTGAATTTTAACCATTTATTACATAATCTCTAGTGATCATGCATCTAGTTATCATAAGAAATAA TTTAAAAGGTTTTGTTGCTGAAAGCAGTAAGTGGTGCAGTAAAATACTTAAGTTATTCAAAGAATGTTATCTTTCTTGCAAGAGTAATTT AAGCACATGGGAAAGATTCTAGACTTTTTGTTTCTTGCAACAACAGTGCCCTCTGCTGCTAGAAACCTTTTTCTACTTACTATCATTTTT ATTGTGGCTTGAGCTCAGTCAATCTGGTGCAGATGAGGCTGGACAACTACTAACCAATAAAATCAGGAGTTTGTACAAAAGTTAAATGGA ACATTATAATTATTTTAAGTAATGTTAATTGAAAAAATTTTTTCTTTTTGACAATATAAAAAACATTTTAAATTTCCTAGAAATGTCTTC AGGGTAATGCCAATTTAAGATCTCTCTTAACTTGTGGCCAAGAAATTCTAGATTTTCCAGCTGACTTTGGTATAATATATATTTATCAGG AACTTCTCTCAGCAGAGAGTACCCATTCTTCGAGTTCAAAGCACAATTTTAAACATGTAAAATGGATATATAATTTGCCAAAGGTAATTA ATTTATTCTTTTTTTCTTAAAGAAGAAAAAGACATTGGTTGTTGTTACAAAAAGTCTAAATTACTGTTGGTTGAAACACAGCAGCTGTGG AGTTCAGTCCAGGCATGAAGACTAAATCTGCTTTACCAAGTAAGGTGTAAGGTTGCATGTTTCAGTCCTCTACCATCCTGCACTGTGAGC AGCACTATACCTGTGCGTTGTCTGAAAGCCTTCCGTATATTCTCCAGCTAAATGGTCGTCTGGTAGCCTTTGCATTTAACAAACTAGCAT GAGGCTTTTTATATCTAAATGCTACGTGATAGACAATTTCAGCTAGCCACATATTGTATGTATGAGATTCATAAAGACTTTCAATCATTT CATTTTCAGACAACTGAAATTTTGTTTAGTATGTGAATTCTTTTTTTGAAATGTATAGTGAATAGGATGTTGCACTGGTGGCAATTCATC >68649_68649_1_PRKAG2-WASL_PRKAG2_chr7_151292431_ENST00000287878_WASL_chr7_123349277_ENST00000223023_length(amino acids)=758AA_BP=290 MVRVMGSAVMDTKKKKDVSSPGGSGGKKNASQKRRSLRVHIPDLSSFAMPLLDGDLEGSGKHSSRKVDSPFGPGSPSKGFFSRGPQPRPS SPMSAPVRPKTSPGSPKTVFPFSYQESPPRSPRRMSFSGIFRSSSKESSPNSNPATSPGGIRFFSRSRKTSGLSSSPSTPTQVTKQHTFP LESYKHEPERLENRIYASSSPPDTGQRFCPSSFQSPTRPPLASPTHYAPSKAAALAAALGPAEAGMLEKLEFEDEAVEDSESGVYMRFMR SHKCYDIVPTSSKLVVFDTTLQTMSSAVVQLYAADRNCMWSKKCSGVACLVKDNPQRSYFLRIFDIKDGKLLWEQELYNNFVYNSPRGYF HTFAGDTCQVALNFANEEEAKKFRKAVTDLLGRRQRKSEKRRDPPNGPNLPMATVDIKNPEITTNRFYGPQVNNISHTKEKKKGKAKKKR LTKADIGTPSNFQHIGHVGWDPNTGFDLNNLDPELKNLFDMCGISEAQLKDRETSKVIYDFIEKTGGVEAVKNELRRQAPPPPPPSRGGP PPPPPPPHNSGPPPPPARGRGAPPPPPSRAPTAAPPPPPPSRPSVAVPPPPPNRMYPPPPPALPSSAPSGPPPPPPSVLGVGPVAPPPPP PPPPPPGPPPPPGLPSDGDHQVPTTAGNKAALLDQIREGAQLKKVEQNSRPVSCSGRDALLDQIRQGIQLKSVADGQESTPPTPAPTSGI -------------------------------------------------------------- >68649_68649_2_PRKAG2-WASL_PRKAG2_chr7_151292431_ENST00000418337_WASL_chr7_123349277_ENST00000223023_length(transcript)=4380nt_BP=395nt GCGGCCGCGCCACCTGCGGCGGCGGCGGCGGCCTCGGGCGGGTGGGGGCAGCGCTCCCGCTCCGCCCCCGGCCCCCGCTGCCCGCGTCCC CTGCCAGGCCCCTCCTCCCGGCGGCGCGGCAGAGCCAGGCCCCAGCGCTCGGCCGGCCGCGAGCCCGCCGGCCGGGGACGAGCGTCGCAG CTCATGCTGATCGCTGTCCTCCTCCTCCCCCTCAGGCGGCGCTGGCGGCGGCCCTGGGACCCGCGGAAGCCGGCATGCTGGAGAAGCTGG AGTTCGAGGACGAAGCAGTAGAAGACTCAGAAAGTGGTGTTTACATGCGATTCATGAGGTCACACAAGTGTTATGACATCGTTCCAACCA GTTCAAAGCTTGTTGTCTTTGATACTACATTACAAACTATGTCTTCAGCAGTGGTGCAGTTATATGCAGCAGATCGGAACTGTATGTGGT CAAAGAAGTGCAGTGGTGTTGCTTGTCTTGTTAAGGACAATCCACAGAGATCTTATTTTTTAAGAATATTTGACATTAAGGATGGGAAAC TATTGTGGGAACAAGAGCTATACAATAACTTTGTATATAATAGTCCTAGAGGATATTTTCATACCTTTGCTGGAGATACTTGTCAAGTTG CTCTTAATTTTGCCAATGAAGAAGAAGCAAAAAAATTTCGAAAAGCAGTTACAGACCTTTTGGGCCGTCGACAAAGGAAATCTGAGAAAA GACGAGATCCCCCAAATGGTCCTAATCTACCCATGGCTACAGTTGATATAAAAAATCCAGAAATCACAACAAATAGATTTTATGGTCCAC AAGTCAACAACATCTCCCATACCAAAGAAAAGAAGAAGGGAAAAGCTAAAAAGAAGAGATTAACCAAGGCAGATATAGGAACACCAAGCA ATTTCCAGCACATTGGACATGTTGGTTGGGATCCAAATACAGGCTTTGATCTGAATAATTTGGATCCAGAATTGAAGAATCTTTTCGATA TGTGTGGAATCTCAGAGGCACAACTTAAAGACAGAGAAACATCAAAAGTTATATATGACTTTATTGAAAAAACAGGAGGTGTTGAAGCTG TTAAAAATGAACTGCGGAGGCAAGCACCACCACCTCCACCACCATCAAGGGGAGGGCCACCTCCTCCTCCTCCCCCTCCACACAACTCAG GTCCTCCTCCTCCTCCTGCTAGGGGAAGAGGCGCTCCTCCCCCACCACCTTCAAGAGCTCCCACAGCTGCACCTCCACCACCGCCTCCTT CCAGGCCAAGTGTAGCAGTCCCTCCACCACCGCCAAATAGGATGTACCCTCCTCCACCTCCAGCCCTTCCCTCCTCAGCACCTTCAGGGC CTCCACCACCACCTCCATCTGTGTTGGGGGTAGGGCCAGTGGCACCACCCCCACCGCCTCCACCTCCACCTCCTCCTGGGCCACCGCCCC CGCCTGGCCTGCCTTCTGATGGGGACCATCAGGTTCCAACTACTGCAGGAAACAAAGCAGCTCTTTTAGATCAAATTAGAGAGGGTGCTC AGCTAAAAAAAGTGGAGCAGAACAGTCGGCCAGTGTCCTGCTCTGGACGAGATGCACTGTTAGACCAGATACGACAGGGTATCCAACTAA AATCTGTGGCTGATGGCCAAGAGTCTACACCACCAACACCTGCACCCACTTCAGGAATTGTGGGTGCATTAATGGAAGTGATGCAGAAAA GGAGCAAAGCCATTCATTCTTCAGATGAAGATGAAGATGAAGATGATGAAGAAGATTTTGAGGATGATGATGAGTGGGAAGACTGATCTA TATATTATATATATATATATATTTTTAAGGTGAAATACTAAACACTACTTTCTGTCTGTGGATTCTGTAAAATTATCATGTAAATGTTCT ACCAATTTGCTGTATATTTTTGTTGCCTTTTTTGCTTTTTTTTAATCTGTGCAATACCTCATTTAATCTGTAAAGGTTTGTCGTAATCCT CTACAAAGCTACTCCCTGTTATTGTGTGCAAGTTTACACCAGGATGCTCACTTGATTTGTGAATATTTTTCATTCCATCAACAAGGGAGT TTAAATACTATATGTGAGACTGACAAAAACCTTAATGTAATTTACTTATAATGCCAGAAGGAAAACACTATTTTCATACCCTACTTTTTC TGTACCTAAATTTTCTTAAAAAAAAATCTAGTATAGCACTACATTCTTTTTTAAGTGATGCAGACCTTAGTTTCTTTAGCCCCTTTATTT TGAATACAATGCTACATATGAATGTTGAAGCTGATACATTGCACAGTTCTGTAGACATCACTACACCGATGTAGTTTCTCAAATTTTAGC AATATGCTCTACATAAAATCACTACAGAGATACTAGTGGGGAAGACGATTAACACACCTCTTACAGTAATACTGCCTGTTATTGGTATAG CAGTGGTATTTGCAGACTGGGATCATAAGGAGCCCTTAAATACTTGTTATTGACTGGGGTTATTTTTATGCTGTAGCAAATGTGACAGGC TCTTTTTAGCAAAATTTTTGAAAATTTTTTTGGTATTACTCTGAAACAAAATTTAAGTTGGAGTTTCAGGGATTTAGGGAGTAGTTTTCA TTCTACATGAACTGAGGTAATATTATGGTAACTCCAATATTTGGTTAAAAAAACTATACAAATCAGAATAGTACTAAAATACTGTAGAAT TTTAGCATTTTTATTTTGCACTTTGTGTGGATTGAGGTGTTCAGAAATACCAACCATAAAAATGTAATCTAGTTGGCAAAGGTGTGCGCT AAAACACGGAACCGAACATGCATTGATTTGGATAACTTTTGAGGGTTTTTGTCAAATAGCATGTGAAGAGTTACATTTTTCTTAAAAGAT TGGTGGTCCCAATGTCAGAGTTCTTGGAACAGATAACTGAATGATAGATTTTTTTTTTTTAAAGATAAAACTTTACAACCTGCACATTTG TTATGCATACTAAATGGTGTGTTAAAATTAGGGTTTCTTTGCCTCTCTACACTACACTAATCTGCCTAAAGGTGGTTGTTTCATATTTAT AATGCTAATTATCATACCTACCTACTTTAAATTTTAGGTAGAAAATTATCTGATTTAAATACAAACATATTTTTCTCACATTGAGTAATA TGCATAATGTAGTTCCAAATGTATTTCATTACTATAGTCACAATATCCAACTAAAAATTACGCTATCTAGAATTGTACCAACCAAAATCT CGTATTGGCAGATCTTGACAGGCTGGACCTGCAAGATGTGGCTTGAATTTTAACCATTTATTACATAATCTCTAGTGATCATGCATCTAG TTATCATAAGAAATAATTTAAAAGGTTTTGTTGCTGAAAGCAGTAAGTGGTGCAGTAAAATACTTAAGTTATTCAAAGAATGTTATCTTT CTTGCAAGAGTAATTTAAGCACATGGGAAAGATTCTAGACTTTTTGTTTCTTGCAACAACAGTGCCCTCTGCTGCTAGAAACCTTTTTCT ACTTACTATCATTTTTATTGTGGCTTGAGCTCAGTCAATCTGGTGCAGATGAGGCTGGACAACTACTAACCAATAAAATCAGGAGTTTGT ACAAAAGTTAAATGGAACATTATAATTATTTTAAGTAATGTTAATTGAAAAAATTTTTTCTTTTTGACAATATAAAAAACATTTTAAATT TCCTAGAAATGTCTTCAGGGTAATGCCAATTTAAGATCTCTCTTAACTTGTGGCCAAGAAATTCTAGATTTTCCAGCTGACTTTGGTATA ATATATATTTATCAGGAACTTCTCTCAGCAGAGAGTACCCATTCTTCGAGTTCAAAGCACAATTTTAAACATGTAAAATGGATATATAAT TTGCCAAAGGTAATTAATTTATTCTTTTTTTCTTAAAGAAGAAAAAGACATTGGTTGTTGTTACAAAAAGTCTAAATTACTGTTGGTTGA AACACAGCAGCTGTGGAGTTCAGTCCAGGCATGAAGACTAAATCTGCTTTACCAAGTAAGGTGTAAGGTTGCATGTTTCAGTCCTCTACC ATCCTGCACTGTGAGCAGCACTATACCTGTGCGTTGTCTGAAAGCCTTCCGTATATTCTCCAGCTAAATGGTCGTCTGGTAGCCTTTGCA TTTAACAAACTAGCATGAGGCTTTTTATATCTAAATGCTACGTGATAGACAATTTCAGCTAGCCACATATTGTATGTATGAGATTCATAA AGACTTTCAATCATTTCATTTTCAGACAACTGAAATTTTGTTTAGTATGTGAATTCTTTTTTTGAAATGTATAGTGAATAGGATGTTGCA >68649_68649_2_PRKAG2-WASL_PRKAG2_chr7_151292431_ENST00000418337_WASL_chr7_123349277_ENST00000223023_length(amino acids)=572AA_BP=104 MPASPARPLLPAARQSQAPALGRPRARRPGTSVAAHADRCPPPPPQAALAAALGPAEAGMLEKLEFEDEAVEDSESGVYMRFMRSHKCYD IVPTSSKLVVFDTTLQTMSSAVVQLYAADRNCMWSKKCSGVACLVKDNPQRSYFLRIFDIKDGKLLWEQELYNNFVYNSPRGYFHTFAGD TCQVALNFANEEEAKKFRKAVTDLLGRRQRKSEKRRDPPNGPNLPMATVDIKNPEITTNRFYGPQVNNISHTKEKKKGKAKKKRLTKADI GTPSNFQHIGHVGWDPNTGFDLNNLDPELKNLFDMCGISEAQLKDRETSKVIYDFIEKTGGVEAVKNELRRQAPPPPPPSRGGPPPPPPP PHNSGPPPPPARGRGAPPPPPSRAPTAAPPPPPPSRPSVAVPPPPPNRMYPPPPPALPSSAPSGPPPPPPSVLGVGPVAPPPPPPPPPPP GPPPPPGLPSDGDHQVPTTAGNKAALLDQIREGAQLKKVEQNSRPVSCSGRDALLDQIRQGIQLKSVADGQESTPPTPAPTSGIVGALME -------------------------------------------------------------- >68649_68649_3_PRKAG2-WASL_PRKAG2_chr7_151292431_ENST00000433631_WASL_chr7_123349277_ENST00000223023_length(transcript)=4744nt_BP=759nt GCTGTGGCCGGAGGTGCAGCCCCGTCAGGACGGCTCCACTCCCTGGCGCCTCACAGACTCTGGGGCTGCGGTGAGGTCGCCCTGAAGACC CCCTGGTGAGGACGCTTGAACCCGGGCTGTCACCTGAGCACAGGCTGCCACTCTGAGCTTTTGGGGCGCCCTGTGCCTGTCGGGCTGATG CTCCTCTGGCTCCCGGCCACCTGGGGCTGACACCGGTTCTGTGGGTCCTGATATGTTCACCTGTCGCCACTCCTGTGGCCACAGCTACCC ATGAAGCGCTTTGGGAGCCTCAGGAGCAACAAGAAACACAAGGACCAAAATCGAAGCACGGAGAGGCGCCAGTCGGAGCCTCATGGCCTT TTCGCCTCCGGCCTCTCCTCCTCTCCGTCAACACCCACCCAAGTGACCAAGCAGCACACGTTTCCCCTGGAATCCTATAAGCACGAGCCT GAACGGTTAGAGAATCGCATCTATGCCTCGTCTTCCCCCCCGGACACAGGGCAGAGGTTCTGCCCGTCTTCCTTCCAGAGCCCGACCAGG CCTCCACTGGCATCACCGACACACTATGCTCCCTCCAAAGCCGCGGCGCTGGCGGCGGCCCTGGGACCCGCGGAAGCCGGCATGCTGGAG AAGCTGGAGTTCGAGGACGAAGTAGAAGACTCAGAAAGTGGTGTTTACATGCGATTCATGAGGTCACACAAGTGTTATGACATCGTTCCA ACCAGTTCAAAGCTTGTTGTCTTTGATACTACATTACAAACTATGTCTTCAGCAGTGGTGCAGTTATATGCAGCAGATCGGAACTGTATG TGGTCAAAGAAGTGCAGTGGTGTTGCTTGTCTTGTTAAGGACAATCCACAGAGATCTTATTTTTTAAGAATATTTGACATTAAGGATGGG AAACTATTGTGGGAACAAGAGCTATACAATAACTTTGTATATAATAGTCCTAGAGGATATTTTCATACCTTTGCTGGAGATACTTGTCAA GTTGCTCTTAATTTTGCCAATGAAGAAGAAGCAAAAAAATTTCGAAAAGCAGTTACAGACCTTTTGGGCCGTCGACAAAGGAAATCTGAG AAAAGACGAGATCCCCCAAATGGTCCTAATCTACCCATGGCTACAGTTGATATAAAAAATCCAGAAATCACAACAAATAGATTTTATGGT CCACAAGTCAACAACATCTCCCATACCAAAGAAAAGAAGAAGGGAAAAGCTAAAAAGAAGAGATTAACCAAGGCAGATATAGGAACACCA AGCAATTTCCAGCACATTGGACATGTTGGTTGGGATCCAAATACAGGCTTTGATCTGAATAATTTGGATCCAGAATTGAAGAATCTTTTC GATATGTGTGGAATCTCAGAGGCACAACTTAAAGACAGAGAAACATCAAAAGTTATATATGACTTTATTGAAAAAACAGGAGGTGTTGAA GCTGTTAAAAATGAACTGCGGAGGCAAGCACCACCACCTCCACCACCATCAAGGGGAGGGCCACCTCCTCCTCCTCCCCCTCCACACAAC TCAGGTCCTCCTCCTCCTCCTGCTAGGGGAAGAGGCGCTCCTCCCCCACCACCTTCAAGAGCTCCCACAGCTGCACCTCCACCACCGCCT CCTTCCAGGCCAAGTGTAGCAGTCCCTCCACCACCGCCAAATAGGATGTACCCTCCTCCACCTCCAGCCCTTCCCTCCTCAGCACCTTCA GGGCCTCCACCACCACCTCCATCTGTGTTGGGGGTAGGGCCAGTGGCACCACCCCCACCGCCTCCACCTCCACCTCCTCCTGGGCCACCG CCCCCGCCTGGCCTGCCTTCTGATGGGGACCATCAGGTTCCAACTACTGCAGGAAACAAAGCAGCTCTTTTAGATCAAATTAGAGAGGGT GCTCAGCTAAAAAAAGTGGAGCAGAACAGTCGGCCAGTGTCCTGCTCTGGACGAGATGCACTGTTAGACCAGATACGACAGGGTATCCAA CTAAAATCTGTGGCTGATGGCCAAGAGTCTACACCACCAACACCTGCACCCACTTCAGGAATTGTGGGTGCATTAATGGAAGTGATGCAG AAAAGGAGCAAAGCCATTCATTCTTCAGATGAAGATGAAGATGAAGATGATGAAGAAGATTTTGAGGATGATGATGAGTGGGAAGACTGA TCTATATATTATATATATATATATATTTTTAAGGTGAAATACTAAACACTACTTTCTGTCTGTGGATTCTGTAAAATTATCATGTAAATG TTCTACCAATTTGCTGTATATTTTTGTTGCCTTTTTTGCTTTTTTTTAATCTGTGCAATACCTCATTTAATCTGTAAAGGTTTGTCGTAA TCCTCTACAAAGCTACTCCCTGTTATTGTGTGCAAGTTTACACCAGGATGCTCACTTGATTTGTGAATATTTTTCATTCCATCAACAAGG GAGTTTAAATACTATATGTGAGACTGACAAAAACCTTAATGTAATTTACTTATAATGCCAGAAGGAAAACACTATTTTCATACCCTACTT TTTCTGTACCTAAATTTTCTTAAAAAAAAATCTAGTATAGCACTACATTCTTTTTTAAGTGATGCAGACCTTAGTTTCTTTAGCCCCTTT ATTTTGAATACAATGCTACATATGAATGTTGAAGCTGATACATTGCACAGTTCTGTAGACATCACTACACCGATGTAGTTTCTCAAATTT TAGCAATATGCTCTACATAAAATCACTACAGAGATACTAGTGGGGAAGACGATTAACACACCTCTTACAGTAATACTGCCTGTTATTGGT ATAGCAGTGGTATTTGCAGACTGGGATCATAAGGAGCCCTTAAATACTTGTTATTGACTGGGGTTATTTTTATGCTGTAGCAAATGTGAC AGGCTCTTTTTAGCAAAATTTTTGAAAATTTTTTTGGTATTACTCTGAAACAAAATTTAAGTTGGAGTTTCAGGGATTTAGGGAGTAGTT TTCATTCTACATGAACTGAGGTAATATTATGGTAACTCCAATATTTGGTTAAAAAAACTATACAAATCAGAATAGTACTAAAATACTGTA GAATTTTAGCATTTTTATTTTGCACTTTGTGTGGATTGAGGTGTTCAGAAATACCAACCATAAAAATGTAATCTAGTTGGCAAAGGTGTG CGCTAAAACACGGAACCGAACATGCATTGATTTGGATAACTTTTGAGGGTTTTTGTCAAATAGCATGTGAAGAGTTACATTTTTCTTAAA AGATTGGTGGTCCCAATGTCAGAGTTCTTGGAACAGATAACTGAATGATAGATTTTTTTTTTTTAAAGATAAAACTTTACAACCTGCACA TTTGTTATGCATACTAAATGGTGTGTTAAAATTAGGGTTTCTTTGCCTCTCTACACTACACTAATCTGCCTAAAGGTGGTTGTTTCATAT TTATAATGCTAATTATCATACCTACCTACTTTAAATTTTAGGTAGAAAATTATCTGATTTAAATACAAACATATTTTTCTCACATTGAGT AATATGCATAATGTAGTTCCAAATGTATTTCATTACTATAGTCACAATATCCAACTAAAAATTACGCTATCTAGAATTGTACCAACCAAA ATCTCGTATTGGCAGATCTTGACAGGCTGGACCTGCAAGATGTGGCTTGAATTTTAACCATTTATTACATAATCTCTAGTGATCATGCAT CTAGTTATCATAAGAAATAATTTAAAAGGTTTTGTTGCTGAAAGCAGTAAGTGGTGCAGTAAAATACTTAAGTTATTCAAAGAATGTTAT CTTTCTTGCAAGAGTAATTTAAGCACATGGGAAAGATTCTAGACTTTTTGTTTCTTGCAACAACAGTGCCCTCTGCTGCTAGAAACCTTT TTCTACTTACTATCATTTTTATTGTGGCTTGAGCTCAGTCAATCTGGTGCAGATGAGGCTGGACAACTACTAACCAATAAAATCAGGAGT TTGTACAAAAGTTAAATGGAACATTATAATTATTTTAAGTAATGTTAATTGAAAAAATTTTTTCTTTTTGACAATATAAAAAACATTTTA AATTTCCTAGAAATGTCTTCAGGGTAATGCCAATTTAAGATCTCTCTTAACTTGTGGCCAAGAAATTCTAGATTTTCCAGCTGACTTTGG TATAATATATATTTATCAGGAACTTCTCTCAGCAGAGAGTACCCATTCTTCGAGTTCAAAGCACAATTTTAAACATGTAAAATGGATATA TAATTTGCCAAAGGTAATTAATTTATTCTTTTTTTCTTAAAGAAGAAAAAGACATTGGTTGTTGTTACAAAAAGTCTAAATTACTGTTGG TTGAAACACAGCAGCTGTGGAGTTCAGTCCAGGCATGAAGACTAAATCTGCTTTACCAAGTAAGGTGTAAGGTTGCATGTTTCAGTCCTC TACCATCCTGCACTGTGAGCAGCACTATACCTGTGCGTTGTCTGAAAGCCTTCCGTATATTCTCCAGCTAAATGGTCGTCTGGTAGCCTT TGCATTTAACAAACTAGCATGAGGCTTTTTATATCTAAATGCTACGTGATAGACAATTTCAGCTAGCCACATATTGTATGTATGAGATTC ATAAAGACTTTCAATCATTTCATTTTCAGACAACTGAAATTTTGTTTAGTATGTGAATTCTTTTTTTGAAATGTATAGTGAATAGGATGT >68649_68649_3_PRKAG2-WASL_PRKAG2_chr7_151292431_ENST00000433631_WASL_chr7_123349277_ENST00000223023_length(amino acids)=639AA_BP=171 MSPLLWPQLPMKRFGSLRSNKKHKDQNRSTERRQSEPHGLFASGLSSSPSTPTQVTKQHTFPLESYKHEPERLENRIYASSSPPDTGQRF CPSSFQSPTRPPLASPTHYAPSKAAALAAALGPAEAGMLEKLEFEDEVEDSESGVYMRFMRSHKCYDIVPTSSKLVVFDTTLQTMSSAVV QLYAADRNCMWSKKCSGVACLVKDNPQRSYFLRIFDIKDGKLLWEQELYNNFVYNSPRGYFHTFAGDTCQVALNFANEEEAKKFRKAVTD LLGRRQRKSEKRRDPPNGPNLPMATVDIKNPEITTNRFYGPQVNNISHTKEKKKGKAKKKRLTKADIGTPSNFQHIGHVGWDPNTGFDLN NLDPELKNLFDMCGISEAQLKDRETSKVIYDFIEKTGGVEAVKNELRRQAPPPPPPSRGGPPPPPPPPHNSGPPPPPARGRGAPPPPPSR APTAAPPPPPPSRPSVAVPPPPPNRMYPPPPPALPSSAPSGPPPPPPSVLGVGPVAPPPPPPPPPPPGPPPPPGLPSDGDHQVPTTAGNK AALLDQIREGAQLKKVEQNSRPVSCSGRDALLDQIRQGIQLKSVADGQESTPPTPAPTSGIVGALMEVMQKRSKAIHSSDEDEDEDDEED -------------------------------------------------------------- >68649_68649_4_PRKAG2-WASL_PRKAG2_chr7_151292431_ENST00000492843_WASL_chr7_123349277_ENST00000223023_length(transcript)=4798nt_BP=813nt GCTTCCGGCAGCTTCTTGCTACTTAAGGACAGCCGGGCTGACGCTCCAGCTGCTGTGGCCGGAGGTGCAGCCCCGTCAGGACGGCTCCAC TCCCTGGCGCCTCACAGACTCTGGGGCTGCGGTGAGGTCGCCCTGAAGACCCCCTGGTGAGGACGCTTGAACCCGGGCTGTCACCTGAGC ACAGGCTGCCACTCTGAGCTTTTGGGGCGCCCTGTGCCTGTCGGGCTGATGCTCCTCTGGCTCCCGGCCACCTGGGGCTGACACCGGTTC TGTGGGTCCTGATATGTTCACCTGTCGCCACTCCTGTGGCCACAGCTACCCATGAAGCGCTTTGGGAGCCTCAGGAGCAACAAGAAACAC AAGGACCAAAATCGAAGCACGGAGAGGCGCCAGTCGGAGCCTCATGGCCTTTTCGCCTCCGGCCTCTCCTCCTCTCCGTCAACACCCACC CAAGTGACCAAGCAGCACACGTTTCCCCTGGAATCCTATAAGCACGAGCCTGAACGGTTAGAGAATCGCATCTATGCCTCGTCTTCCCCC CCGGACACAGGGCAGAGGTTCTGCCCGTCTTCCTTCCAGAGCCCGACCAGGCCTCCACTGGCATCACCGACACACTATGCTCCCTCCAAA GCCGCGGCGCTGGCGGCGGCCCTGGGACCCGCGGAAGCCGGCATGCTGGAGAAGCTGGAGTTCGAGGACGAAGCAGTAGAAGACTCAGAA AGTGGTGTTTACATGCGATTCATGAGGTCACACAAGTGTTATGACATCGTTCCAACCAGTTCAAAGCTTGTTGTCTTTGATACTACATTA CAAACTATGTCTTCAGCAGTGGTGCAGTTATATGCAGCAGATCGGAACTGTATGTGGTCAAAGAAGTGCAGTGGTGTTGCTTGTCTTGTT AAGGACAATCCACAGAGATCTTATTTTTTAAGAATATTTGACATTAAGGATGGGAAACTATTGTGGGAACAAGAGCTATACAATAACTTT GTATATAATAGTCCTAGAGGATATTTTCATACCTTTGCTGGAGATACTTGTCAAGTTGCTCTTAATTTTGCCAATGAAGAAGAAGCAAAA AAATTTCGAAAAGCAGTTACAGACCTTTTGGGCCGTCGACAAAGGAAATCTGAGAAAAGACGAGATCCCCCAAATGGTCCTAATCTACCC ATGGCTACAGTTGATATAAAAAATCCAGAAATCACAACAAATAGATTTTATGGTCCACAAGTCAACAACATCTCCCATACCAAAGAAAAG AAGAAGGGAAAAGCTAAAAAGAAGAGATTAACCAAGGCAGATATAGGAACACCAAGCAATTTCCAGCACATTGGACATGTTGGTTGGGAT CCAAATACAGGCTTTGATCTGAATAATTTGGATCCAGAATTGAAGAATCTTTTCGATATGTGTGGAATCTCAGAGGCACAACTTAAAGAC AGAGAAACATCAAAAGTTATATATGACTTTATTGAAAAAACAGGAGGTGTTGAAGCTGTTAAAAATGAACTGCGGAGGCAAGCACCACCA CCTCCACCACCATCAAGGGGAGGGCCACCTCCTCCTCCTCCCCCTCCACACAACTCAGGTCCTCCTCCTCCTCCTGCTAGGGGAAGAGGC GCTCCTCCCCCACCACCTTCAAGAGCTCCCACAGCTGCACCTCCACCACCGCCTCCTTCCAGGCCAAGTGTAGCAGTCCCTCCACCACCG CCAAATAGGATGTACCCTCCTCCACCTCCAGCCCTTCCCTCCTCAGCACCTTCAGGGCCTCCACCACCACCTCCATCTGTGTTGGGGGTA GGGCCAGTGGCACCACCCCCACCGCCTCCACCTCCACCTCCTCCTGGGCCACCGCCCCCGCCTGGCCTGCCTTCTGATGGGGACCATCAG GTTCCAACTACTGCAGGAAACAAAGCAGCTCTTTTAGATCAAATTAGAGAGGGTGCTCAGCTAAAAAAAGTGGAGCAGAACAGTCGGCCA GTGTCCTGCTCTGGACGAGATGCACTGTTAGACCAGATACGACAGGGTATCCAACTAAAATCTGTGGCTGATGGCCAAGAGTCTACACCA CCAACACCTGCACCCACTTCAGGAATTGTGGGTGCATTAATGGAAGTGATGCAGAAAAGGAGCAAAGCCATTCATTCTTCAGATGAAGAT GAAGATGAAGATGATGAAGAAGATTTTGAGGATGATGATGAGTGGGAAGACTGATCTATATATTATATATATATATATATTTTTAAGGTG AAATACTAAACACTACTTTCTGTCTGTGGATTCTGTAAAATTATCATGTAAATGTTCTACCAATTTGCTGTATATTTTTGTTGCCTTTTT TGCTTTTTTTTAATCTGTGCAATACCTCATTTAATCTGTAAAGGTTTGTCGTAATCCTCTACAAAGCTACTCCCTGTTATTGTGTGCAAG TTTACACCAGGATGCTCACTTGATTTGTGAATATTTTTCATTCCATCAACAAGGGAGTTTAAATACTATATGTGAGACTGACAAAAACCT TAATGTAATTTACTTATAATGCCAGAAGGAAAACACTATTTTCATACCCTACTTTTTCTGTACCTAAATTTTCTTAAAAAAAAATCTAGT ATAGCACTACATTCTTTTTTAAGTGATGCAGACCTTAGTTTCTTTAGCCCCTTTATTTTGAATACAATGCTACATATGAATGTTGAAGCT GATACATTGCACAGTTCTGTAGACATCACTACACCGATGTAGTTTCTCAAATTTTAGCAATATGCTCTACATAAAATCACTACAGAGATA CTAGTGGGGAAGACGATTAACACACCTCTTACAGTAATACTGCCTGTTATTGGTATAGCAGTGGTATTTGCAGACTGGGATCATAAGGAG CCCTTAAATACTTGTTATTGACTGGGGTTATTTTTATGCTGTAGCAAATGTGACAGGCTCTTTTTAGCAAAATTTTTGAAAATTTTTTTG GTATTACTCTGAAACAAAATTTAAGTTGGAGTTTCAGGGATTTAGGGAGTAGTTTTCATTCTACATGAACTGAGGTAATATTATGGTAAC TCCAATATTTGGTTAAAAAAACTATACAAATCAGAATAGTACTAAAATACTGTAGAATTTTAGCATTTTTATTTTGCACTTTGTGTGGAT TGAGGTGTTCAGAAATACCAACCATAAAAATGTAATCTAGTTGGCAAAGGTGTGCGCTAAAACACGGAACCGAACATGCATTGATTTGGA TAACTTTTGAGGGTTTTTGTCAAATAGCATGTGAAGAGTTACATTTTTCTTAAAAGATTGGTGGTCCCAATGTCAGAGTTCTTGGAACAG ATAACTGAATGATAGATTTTTTTTTTTTAAAGATAAAACTTTACAACCTGCACATTTGTTATGCATACTAAATGGTGTGTTAAAATTAGG GTTTCTTTGCCTCTCTACACTACACTAATCTGCCTAAAGGTGGTTGTTTCATATTTATAATGCTAATTATCATACCTACCTACTTTAAAT TTTAGGTAGAAAATTATCTGATTTAAATACAAACATATTTTTCTCACATTGAGTAATATGCATAATGTAGTTCCAAATGTATTTCATTAC TATAGTCACAATATCCAACTAAAAATTACGCTATCTAGAATTGTACCAACCAAAATCTCGTATTGGCAGATCTTGACAGGCTGGACCTGC AAGATGTGGCTTGAATTTTAACCATTTATTACATAATCTCTAGTGATCATGCATCTAGTTATCATAAGAAATAATTTAAAAGGTTTTGTT GCTGAAAGCAGTAAGTGGTGCAGTAAAATACTTAAGTTATTCAAAGAATGTTATCTTTCTTGCAAGAGTAATTTAAGCACATGGGAAAGA TTCTAGACTTTTTGTTTCTTGCAACAACAGTGCCCTCTGCTGCTAGAAACCTTTTTCTACTTACTATCATTTTTATTGTGGCTTGAGCTC AGTCAATCTGGTGCAGATGAGGCTGGACAACTACTAACCAATAAAATCAGGAGTTTGTACAAAAGTTAAATGGAACATTATAATTATTTT AAGTAATGTTAATTGAAAAAATTTTTTCTTTTTGACAATATAAAAAACATTTTAAATTTCCTAGAAATGTCTTCAGGGTAATGCCAATTT AAGATCTCTCTTAACTTGTGGCCAAGAAATTCTAGATTTTCCAGCTGACTTTGGTATAATATATATTTATCAGGAACTTCTCTCAGCAGA GAGTACCCATTCTTCGAGTTCAAAGCACAATTTTAAACATGTAAAATGGATATATAATTTGCCAAAGGTAATTAATTTATTCTTTTTTTC TTAAAGAAGAAAAAGACATTGGTTGTTGTTACAAAAAGTCTAAATTACTGTTGGTTGAAACACAGCAGCTGTGGAGTTCAGTCCAGGCAT GAAGACTAAATCTGCTTTACCAAGTAAGGTGTAAGGTTGCATGTTTCAGTCCTCTACCATCCTGCACTGTGAGCAGCACTATACCTGTGC GTTGTCTGAAAGCCTTCCGTATATTCTCCAGCTAAATGGTCGTCTGGTAGCCTTTGCATTTAACAAACTAGCATGAGGCTTTTTATATCT AAATGCTACGTGATAGACAATTTCAGCTAGCCACATATTGTATGTATGAGATTCATAAAGACTTTCAATCATTTCATTTTCAGACAACTG AAATTTTGTTTAGTATGTGAATTCTTTTTTTGAAATGTATAGTGAATAGGATGTTGCACTGGTGGCAATTCATCATGGAGCATAATAAAA >68649_68649_4_PRKAG2-WASL_PRKAG2_chr7_151292431_ENST00000492843_WASL_chr7_123349277_ENST00000223023_length(amino acids)=640AA_BP=172 MSPLLWPQLPMKRFGSLRSNKKHKDQNRSTERRQSEPHGLFASGLSSSPSTPTQVTKQHTFPLESYKHEPERLENRIYASSSPPDTGQRF CPSSFQSPTRPPLASPTHYAPSKAAALAAALGPAEAGMLEKLEFEDEAVEDSESGVYMRFMRSHKCYDIVPTSSKLVVFDTTLQTMSSAV VQLYAADRNCMWSKKCSGVACLVKDNPQRSYFLRIFDIKDGKLLWEQELYNNFVYNSPRGYFHTFAGDTCQVALNFANEEEAKKFRKAVT DLLGRRQRKSEKRRDPPNGPNLPMATVDIKNPEITTNRFYGPQVNNISHTKEKKKGKAKKKRLTKADIGTPSNFQHIGHVGWDPNTGFDL NNLDPELKNLFDMCGISEAQLKDRETSKVIYDFIEKTGGVEAVKNELRRQAPPPPPPSRGGPPPPPPPPHNSGPPPPPARGRGAPPPPPS RAPTAAPPPPPPSRPSVAVPPPPPNRMYPPPPPALPSSAPSGPPPPPPSVLGVGPVAPPPPPPPPPPPGPPPPPGLPSDGDHQVPTTAGN KAALLDQIREGAQLKKVEQNSRPVSCSGRDALLDQIRQGIQLKSVADGQESTPPTPAPTSGIVGALMEVMQKRSKAIHSSDEDEDEDDEE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PRKAG2-WASL |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PRKAG2-WASL |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PRKAG2-WASL |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |